top of page

Wed, May 12

|

Webinar via Zoom

Low-Dose Naltrexone - What We Know, Mechanisms, and Evidence

Nat Jones RPh, FAPC│PCCA Clinical Compounding Pharmacist

Registration is Closed
See other events
Low-Dose Naltrexone - What We Know, Mechanisms, and Evidence
Low-Dose Naltrexone - What We Know, Mechanisms, and Evidence

Time & Location

May 12, 2021, 6:30 PM – 8:00 PM

Webinar via Zoom

About the Event

Explore the benefits of Low-Dose Naltrexone (LDN) with leading pharmacist Nat Jones. Hear about the history of LDN to its use in supporting patients with auto immune disorders. We will also cover the use of LDN with patients struggling with chronic pain, mental health issues and more. Nat will use testimonials and research throughout the presentation to support the use of Low-Dose Naltrexone. Read more about Nat Jones below.

Nat Jones

RPh, FAPC│PCCA Clinical Compounding Pharmacist

Nat graduated from the Virginia Commonwealth University, Medical College of Virginia’s School of Pharmacy in 1979. In 2014, after 20 years of owning a compounding pharmacy in Virginia, he joined PCCA’s Clinical Services team in Houston Texas. He is an international speaker, who for decades has given CE lectures at medical professional seminars and webinars on numerous topics, including: general compounding, wound care, pain management, nutrition, otolaryngology, women’s health, sexual dysfunction, insulin resistance, hormone replacement therapy for men and women, neurotransmitter imbalance and dermatology. In 2010, Nat was awarded a full fellowship in the Alliance for Pharmacy Compounding. Nat has published many articles in lay magazines along with articles and case studies in professional journals.

Share This Event

bottom of page